Abstract 711

Background:

Recurrent pregnancy loss (RPL) is a multifactorial condition. The effects of antithrombin (SERPINC1), protein C (PROC), thrombomodulin (THBD) and tissue factor pathway inhibitor (TFPI) gene polymorphisms in the risk of having RPL are unknown.

Aims:

To determine the effects of SERPINC1, PROC, THBD and TFPI gene polymorphisms in the risk of having RPL.

Methods:

One hundred and fifteen non-pregnant women with three consecutive losses prior to 20 weeks of pregnancy without carrying a fetus to viability (primary RPL) and 253 healthy fertile non-pregnant women who had at least two children and no known pregnancy losses were studied. The PROC (rs1799809 and rs1799808), SERPINC1 (rs2227589), THBD (rs1042579) and TFPI (rs10931292 and rs8176592) gene polymorphisms were detected respectively by Real Time PCR.

Results:

No difference was observed among the genotypes frequencies for PROC 2418A>G, PROC 2405C>T, THBD 1418C>T and TFPI T-33C polymorphisms in two groups (Table 1, P>0.05). However, the carriers of 140T allele (CT + TT genotypes) for SERPINC1 C+140T polymorphism had 1.73 (95% CI: 1.00 – 2.99) times risk of having RPL. Furthermore, the carriers of TC + CC genotypes for TFPI T-287C polymorphism had a protection effect of having RPL (OR: 0.48, 95% CI 0.27– 0.86).

Conclusions:

The variant of SERPINC1 C+140T polymorphism is associated with higher risk of having RPL while the variant of TFPI T-287C polymorphism is associated with a protection effect.

Table 1 –

Genotypes distributions of investigated SNPs

PolymorphismSNP IDChrChr positionGenotypesRPL groupControl groupOR (CI 95%)P valor
PROC 2418A>G rs1799809 128175875 AA 37 (32.5) 88 (34.8) 1.00  
    AG + GG 77 (67.5) 165 (65.2) 1.11 (0.69–1.78) 0.663 
         
PROC 2405C>T rs1799808 128175862 CC 42 (36.8) 87 (34.4) 1.00  
    CT + TT 72 (63.2) 166 (65.6) 0.90 (0.57–1.42) 0.649 
         
SERPINC1 C+140T rs2227589 173886216 CC 86 (75.4) 213 (84.2) 1.00  
    CT + TT 28 (24.6) 40 (15.8) 1.73 (1.00–2.99) 0.047 
         
THBD c.1418C>T rs1042579 20 23028724 CC 87 (76.3) 195 (77.1) 1.00  
    CT + TT 27 (23.7) 58 (22.9) 1.04 (0.62–1.76) 0.873 
         
TFPI T-287C rs10931292 188419479 TT 97 (85.1) 185 (73.1) 1.00  
    TC + CC 17 (14.9) 68 (26.9) 0.48 (0.27–0.86) 0.013 
         
TFPI T-33C rs8176592 188332692 TT 51 (44.7) 114 (45.1) 1.00  
    TC + CC 63 (55.3) 139 (54.9) 1.01 (0.65–1.58) 0.954 
PolymorphismSNP IDChrChr positionGenotypesRPL groupControl groupOR (CI 95%)P valor
PROC 2418A>G rs1799809 128175875 AA 37 (32.5) 88 (34.8) 1.00  
    AG + GG 77 (67.5) 165 (65.2) 1.11 (0.69–1.78) 0.663 
         
PROC 2405C>T rs1799808 128175862 CC 42 (36.8) 87 (34.4) 1.00  
    CT + TT 72 (63.2) 166 (65.6) 0.90 (0.57–1.42) 0.649 
         
SERPINC1 C+140T rs2227589 173886216 CC 86 (75.4) 213 (84.2) 1.00  
    CT + TT 28 (24.6) 40 (15.8) 1.73 (1.00–2.99) 0.047 
         
THBD c.1418C>T rs1042579 20 23028724 CC 87 (76.3) 195 (77.1) 1.00  
    CT + TT 27 (23.7) 58 (22.9) 1.04 (0.62–1.76) 0.873 
         
TFPI T-287C rs10931292 188419479 TT 97 (85.1) 185 (73.1) 1.00  
    TC + CC 17 (14.9) 68 (26.9) 0.48 (0.27–0.86) 0.013 
         
TFPI T-33C rs8176592 188332692 TT 51 (44.7) 114 (45.1) 1.00  
    TC + CC 63 (55.3) 139 (54.9) 1.01 (0.65–1.58) 0.954 

Chr: chromosome; SNP: single nucleotide polymorphisms; RPL: recurrent pregnancy loss.

The data are absolute (relative) frequencies.

Financing: Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP 2007/57605-0)

Disclosures:

No relevant conflicts of interest to declare.

Author notes

*

Asterisk with author names denotes non-ASH members.

Sign in via your Institution